Showing results (81-90 of 96) with videos related to
Sort By:
Pageof 10
The American Journal of Pathology|November 7, 2001
CCR1+/CCR5+ mononuclear phagocytes accumulate in the central nervous system of patients with multiple sclerosisC Trebst, T L Sørensen, P Kivisäkk, et al.European Journal of Neurology|June 30, 2009
Identification of new sensitive biomarkers for the in vivo response to interferon-beta treatment in multiple sclerosis using DNA-array evaluationF Sellebjerg, M Krakauer, D Hesse, et al.European Journal of Neurology|December 18, 2008
Methylprednisolone does not restore biological response in multiple sclerosis patients with neutralizing antibodies against interferon-βD Hesse, J L Frederiksen, N Koch-Henriksen, et al.Journal of Neuroimmunology|October 27, 2019
Expression of melanoma cell adhesion molecule-1 (MCAM-1) in natalizumab-treated multiple sclerosisE R Petersen, C Ammitzbøll, H B Søndergaard, et al.Multiple Sclerosis and Related Disorders|September 21, 2016
Shift work at young age is associated with increased risk of multiple sclerosis in a Danish populationS Gustavsen, H B Søndergaard, D B Oturai, et al.Journal of the Neurological Sciences|September 2, 2025
Serum neurofilament light chain levels are associated with cognitive decline in a consecutive cohort of patients with Alzheimer's diseaseC S Musaeus, H S Gleerup, F K Clemmensen, et al.Multiple Sclerosis (Houndmills, Basingstoke, England)|August 30, 2000
A meta-analysis of methylprednisolone in recovery from multiple sclerosis exacerbationsD M Miller, B Weinstock-Guttman, F Béthoux, et al.The Journal of Clinical Investigation|March 17, 1999
Expression of specific chemokines and chemokine receptors in the central nervous system of multiple sclerosis patientsT L Sørensen, M Tani, J Jensen, et al.Multiple Sclerosis and Related Disorders|January 12, 2018
Disability in progressive MS is associated with T2 lesion changesC Ammitzbøll, T B Dyrby, M Lyksborg, et al.European Journal of Neurology|February 6, 2016
Minocycline added to subcutaneous interferon β-1a in multiple sclerosis: randomized RECYCLINE studyP S Sørensen, F Sellebjerg, J Lycke, et al.Pageof 10